Fortis Healthcare delivered strong Q2 FY26 results.

Consolidated revenue jumped 17.3% YoY to 2,331 Cr, with Profit After Tax soaring 70.3% to 329 Cr. **Business Performance:** Hospital business revenue grew 19.3% to 1,974 Cr, driven by key specialties like Oncology (+29%) and Renal Sciences (+22%), and a 26% rise in international patient revenue.

Diagnostics revenue grew 7.3% to 400 Cr, with improved operating EBITDA margins. **Growth Drivers/Strategy:** The company is accelerating its expansion, securing a 15-year lease for a 200-bedded hospital in Greater Noida and an O&M agreement for a new 550-bed hospital in Lucknow.

Agilus Diagnostics expanded its network with 200+ new customer touchpoints. **Recent Developments:** Capacity additions are ongoing, including a new 50-bed tower in Faridabad, operationalized in Q2 FY26, and significant bed additions at Manesar, FMRI, and Noida.

Strategic acquisitions contributed to increased operational beds. **Key Financial Metrics:** Consolidated operating EBITDA margin expanded to 23.9% from 21.9% YoY.

Net debt stood at 2,219 Cr, with Net Debt to EBITDA at 0.96x, following strategic acquisitions.

EPS reached 4.26. **Management Outlook:** Management highlights sustained healthy growth momentum across both hospital and diagnostics segments, expecting continued positive recovery in diagnostics.